Olcegepant is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide (CGRP) receptor, primarily explored for the prevention of migraines in adults. CGRP is a neuropeptide that plays a significant role in migraine pathophysiology, and its receptors are found in the trigeminal ganglion and the central nervous system. By blocking the CGRP receptor, olcegepant aims to prevent the activation of pain pathways associated with migraines. Source summary: Olcegepant is a CGRP receptor antagonist research chemical for biochemical studies; explore properties, handling, and reference data.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Neurological Disease | CGRP Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.